Evidence map›Paper›PMID 30337567›Full record

ArticleScientific reports2018

Alendronate release from calcium phosphate cement for bone regeneration in osteoporotic conditions.

Claire I A van Houdt, Paulo R Gabbai-Armelin, Paula M Lopez-Perez, Dietmar J O Ulrich, John A Jansen, Ana Claudia M Renno, Jeroen J J P van den Beucken

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Protective effect of3 Biotech · 2024
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Claire I A van HoudtRadboudumc, Department of Regenerative Biomaterials, Nijmegen, The Netherlands.
Paulo R Gabbai-ArmelinLaboratory of Biomaterials and Tissue Engineering, Department Biosciences, Federal University of São Paulo (UNIFESP), Santos, São Paulo, Brazil.
Paula M Lopez-PerezRadboudumc, Department of Regenerative Biomaterials, Nijmegen, The Netherlands.
Dietmar J O UlrichRadboudumc, Department of Plastic, Reconstructive and Hand Surgery, Nijmegen, The Netherlands.
John A JansenRadboudumc, Department of Regenerative Biomaterials, Nijmegen, The Netherlands.
Ana Claudia M RennoLaboratory of Biomaterials and Tissue Engineering, Department Biosciences, Federal University of São Paulo (UNIFESP), Santos, São Paulo, Brazil.
Jeroen J J P van den BeuckenRadboudumc, Department of Regenerative Biomaterials, Nijmegen, The Netherlands. Jeroen.vandenBeucken@radboudumc.nl.ORCID http://orcid.org/0000-0002-0301-1966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis represents a major health problem in terms of compromising bone strength and increasing the risk of bone fractures. It can be medically treated with bisphosphonates, which act systemically upon oral or venous administration. Further, bone regenerative treatments in osteoporotic conditions present a challenge. Here, we focused on the development of a synthetic bone substitute material with local diminishing effects on osteoporosis. Composites were created using calcium phosphate cement (CPC; 60 wt%) and polylactic-co-glycolic acid (PLGA; 40 wt%), which were loaded with alendronate (ALN). In vitro results showed that ALN-loaded CPC/PLGA composites presented clinically suitable properties, including setting times, appropriate compressive strength, and controlled release of ALN, the latter being dependent on composite degradation. Using a rat femoral condyle bone defect model in osteoporotic animals, ALN-loaded CPC/PLGA composites demonstrated stimulatory effects on bone formation both within and outside the defect region.

Indexed as

Bone RegenerationOsteogenesisAlendronateAnimalsBone CementsBone Density Conservation AgentsCalcium PhosphatesFemaleMaterials TestingOsteoporosisPolyglycolic AcidRatsRats, WistarAlendronateBone CementsBone Density Conservation Agentscalcium phosphate polylactic-co-glycolic acid compositeCalcium PhosphatesPolyglycolic Acid

Identifiers

PMID30337567
PMCPMC6194021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.